|
IcoCell− Chassis for Enhanced Mammalian Cell Line Development and Engineering
| acronym: |
IcoCell |
| start: |
2015-04-01 |
| end: |
2015-09-30 |
| |
| programme: |
H2020 - Horisont 2020 |
| sub-programme: |
LEIT - Juhtkoht tööstustehnoloogias |
| instrument: |
SME-1 |
| call identifier: |
H2020-SMEINST-1-2014 |
| project number: |
663613 |
| duration in months: |
6 |
| partner count: |
1 |
| |
| abstract: |
The opportunity to focus on the production of biopharmaceuticals is often taken from SMEs since huge amount of resources is required for the development of high-producer cell lines. We envision that our parental cell factories will increase the efficiency of cell line engineering and will effectively reduce the time-to-market for mammalian cell-based products. It allows SMEs to leverage their traditional strengths of adaptability and creativity, and to develop novel products for biotechnology industries. |
| partner no and role |
partner name |
country |
contact person |
web page |
| 1 |
coordinator |
ICOSAGEN CELL FACTORY OU |
EE |
Andres TOVER |
http://icosagen.com |
|
